The authors delve in to how various courts address claim construction, as well as some practical guidance for practitioners.

President Trump's executive order on drug pricing caused a surprising rally in pharmaceutical stocks. Read my analysis of PJP ETF.

Indian drugmaker Mankind Pharma reported a fourth-quarter profit that beat analysts' estimates on Wednesday, driven by strong ...

Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...

Investors need to pay close attention to Aurinia Pharmaceuticals (AUPH) stock based on the movements in the options market lately.

According to Benzinga Pro, Regeneron Pharmaceuticals's peer group average for short interest as a percentage of float is 6.89 ...

Regeneron Pharmaceuticals Inc.'s victory against Amgen Inc. over anticompetitive drug bundling reinforces the necessity for ...

The pharmaceutical trade group PhRMA has come out strongly against tariffs, warning that every dollar collected in tariffs means one less dollar invested in U.S. biopharmaceutical research and ...

India's GlaxoSmithKline Pharmaceuticals reported a higher fourth-quarter profit on Tuesday, led by steady demand for its generic drugs.

Kieran Gostin, a Wilkinson Stekloff partner who handled oral arguments for Visa, argued that there was “tension” in the DOJ’s ...

AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity. Here’s how to do it.